Category

Events
PepTalk
CAMBRIDGE, MA, AND PARIS, FRANCE, January 9, 2017 – HiFiBiO SAS today announced that the latest results from their CelliGO™ platform will be presented by Dr. Roshan Kumar, Group Leader in Cambridge, as part of the ‘Emerging Technologies for Antibody Discovery’ track at PEPTalk 2017 in San Diego. The presentations will feature the latest achievements...
Read More
CAMBRIDGE, MA, AND PARIS, FRANCE, November 11, 2016 – HiFiBiO SAS today announced that the latest results from their CelliGO™ platform will be presented by Senior Scientist and Project Leader Dr. Annabelle Gerard as part of the 2016 European Antibody Conference taking place in Basel, Switzerland. The presentations will feature the latest achievements in deep mining...
Read More
CAMBRIDGE, MA, AND PARIS, FRANCE, November 7, 2016 – HiFiBiO SAS today announced that the latest results from their CelliGO™ platform will be presented by Senior Scientists and Project Leaders, Dr Adam Woolfe and Dr. Marcel Reichen as part of the 2016 Human Antibodies and Hybridomas Conference. The presentations will feature the latest achievements in deep...
Read More
Paris, France and Cambridge, MA –May 16th, 2016–In an interactive session at BioInternational 2016, HiFiBiO, Adimab, F-Star and Innovative Targeting Solutions will join together to present next-generation therapeutic antibody technologies designed to help deliver the next wave of antibody therapeutics to the pipeline. Session Title: Tackling Tough Targets with a New Wave of Antibody Technologies...
Read More
Screening entire immune repertoires generates diverse panels of therapeutic antibody leads November 23, 2015 10:00 AM Eastern Standard Time CAMBRIDGE, Mass. & PARIS–(BUSINESS WIRE)–HiFiBiO SAS today announced that the latest results from their CelliGOTM platform will be presented by Chief Scientific Officer, Dr. Allan Jensen, Dec. 7-10 San Diego, California. The presentation, will be on Tuesday, Dec. 8 at 13:45...
Read More
PARIS, FRANCE, October 27, 2015 – HiFiBiO SAS announced today that the company’s next generation antibody discovery platform will be presented at the Seventh Annual PEGS Europe 2015 Protein and Antibody Engineering Summit, Nov. 2-6 in Lisbon, Portugal. The presentation, by William S. Somers, Ph.D., Vice President, Global Biotherapeutic Technologies at Pfizer Inc., will be on Tuesday, Nov 3 at...
Read More
Paris, France, 12 June 2015—HiFiBiO will present its novel, integrated platform for the discovery of differentiated therapeutic antibodies at the Next Generation Antibodies and Protein Analysis Conference: Tools and Technologies, on 15 June 2015, in Ghent, Belgium. In a presentation, “Deep Mining of Immune Repertoires”, HiFiBiO’s Chief Scientific Officer, Allan Jensen, PhD, will describe the company’s...
Read More